Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-22 · accession 0001628280-24-012917 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-25 | 2024-03-22+ | MYGN | Haas Kevin Richard | CTO | F - Tax | $22.24 | -4,575 | 132.1K | -3% | -$101.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-24 | F | D | 1,172 | $22.24 | 133,815 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-22 | F | D | 1,685 | $22.24 | 134,987 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-24 | F | D | 1,718 | $22.24 | 132,097 | D | — | — |